← back to search

Amy Frary

KU Leuven · BE
Area of research
Spectroscopy · Atomic and Molecular Physics, and Optics
Research interest
Research interests include Medicine, Metabolism, Chemistry, Biology, Carbohydrate metabolism, and Melanoma.
h-index
citations
945
works
12
NIH funding
primary concept
email

Recent publications

Measuring extracellular human brain pH and amino acid metabolism with hyperpolarized [1- <sup>13</sup> C]pyruvate
medRxiv 2023cited by 1position: middledoi
Deuterium metabolic imaging and hyperpolarized 13C-MRI of the normal human brain at clinical field strength reveals differential cerebral metabolism
NeuroImage 2022cited by 87position: middledoi
Hyperpolarized 13C-Pyruvate Metabolism as a Surrogate for Tumor Grade and Poor Outcome in Renal Cell Carcinoma—A Proof of Principle Study
Cancers 2022cited by 51position: middledoi
GWAS meta-analysis of intrahepatic cholestasis of pregnancy implicates multiple hepatic genes and regulatory elements
Nature Communications 2022cited by 45position: middledoi
Deuterium metabolic imaging and hyperpolarized <sup>13</sup> C-MRI of the normal human brain at clinical field strength reveals differential cerebral metabolism
medRxiv 2022cited by 1position: middledoi
Non-contrast MRI can accurately characterize adnexal masses: a retrospective study
European Radiology 2021cited by 43position: middledoi
Multiparametric MRI of early tumor response to immune checkpoint blockade in metastatic melanoma
Journal for ImmunoTherapy of Cancer 2021cited by 28position: middledoi
Multiparametric MRI of Early Tumor Response to Immune Checkpoint Blockade in Metastatic Melanoma
medRxiv 2021cited by 3position: middledoi
Imaging breast cancer using hyperpolarized carbon-13 MRI
Proceedings of the National Academy of Sciences 2020cited by 202position: middledoi
Germline selection shapes human mitochondrial DNA diversity
Science 2019cited by 250position: middledoi
Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data
Scientific Reports 2018cited by 90position: middledoi
Phenotypic Characterization of <i>EIF2AK4</i> Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension
Circulation 2017cited by 144position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mary A. McLean · Cambridge University Hospitals NHS Foundation Trust5 papers (2021–2023)Ferdia A. Gallagher · University of Cambridge5 papers (2021–2023)Joshua Kaggie · University of Cambridge5 papers (2021–2023)Martin J. Graves · Cancer Research UK Cambridge Center5 papers (2021–2023)Ashley Grimmer · Cambridge University Hospitals NHS Foundation Trust3 papers (2022–2023)Rolf F. Schulte · Cambridge University Hospitals NHS Foundation Trust3 papers (2022–2023)Tomasz Matys · Cambridge University Hospitals NHS Foundation Trust3 papers (2022–2023)Bruno Carmo · Cambridge University Hospitals NHS Foundation Trust3 papers (2021–2021)Alixander S. Khan · Cambridge University Hospitals NHS Foundation Trust3 papers (2022–2023)M. Locke · Cambridge University Hospitals NHS Foundation Trust3 papers (2022–2023) · 2 papers (2021–2021)Andrew N. Priest · University of Cambridge2 papers (2021–2021)Elizabeth Latimer · Cambridge University Hospitals NHS Foundation Trust2 papers (2022–2023)Doreen Milne · Cambridge University Hospitals NHS Foundation Trust2 papers (2021–2021) · 2 papers (2021–2021)Kevin M. Brindle · Cancer Research UK Cambridge Center2 papers (2021–2021)Jean‐Martin Lapointe · McGill University Health Centre2 papers (2021–2021)Ilse Patterson · Cambridge University Hospitals NHS Foundation Trust2 papers (2021–2021)Luigi Aloj · Cambridge University Hospitals NHS Foundation Trust2 papers (2021–2021) · 2 papers (2021–2021)